Diagnostic Validity of Chronic Kidney Disease in Health Claims Data Over Time: Results from a Cohort of Community-Dwelling Older Adults in Germany

References

• Mues KE, Liede A, Liu J, et al. Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017;9:267–277. doi:10.2147/CLEP.S105613
   PubMed Web of Science ®Google Scholar
• Thompson AM, Southworth MR. Real world data and evidence: support for drug approval: applications to kidney diseases. Clin J Am Soc Nephrol. 2019;14(10):1531–1532. doi:10.2215/CJN.02790319
   PubMed Web of Science ®Google Scholar
• Corrigan-Curay J, Sacks L, Woodcock J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. JAMA. 2018;320(9):867–868. doi:10.1001/jama.2018.10136
   PubMed Web of Science ®Google Scholar
• Yang C, Yang Z, Wang J, et al. Estimation of prevalence of kidney disease treated with dialysis in China: a study of insurance claims data. Am J Kidney Dis. 2021;77(6):889–897. doi:10.1053/j.ajkd.2020.11.021
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Ks K, Dovgan E, et al. Machine learning prediction models for chronic kidney disease using national health insurance claim data in Taiwan. Healthcare. 2021;9(5):546. doi:10.3390/healthcare9050546
   Web of Science ®Google Scholar
• Krishnan M, Weinhandl ED, Jackson S, Gilbertson DT, Lacson E. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data. Am J Kidney Dis. 2015;66(5):802–812. doi:10.1053/j.ajkd.2015.04.015
   PubMed Web of Science ®Google Scholar
• Gandjour A, Armsen W, Wehmeyer W, Multmeier J, Tschulena U, Alam K. Costs of patients with chronic kidney disease in Germany. PLoS One. 2020;15(4):e0231375. doi:10.1371/journal.pone.0231375
   PubMed Web of Science ®Google Scholar
• van Oosten MJM, Logtenberg SJJ, Leegte MJH, et al. Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data. Nephrol Dial Transplant. 2020;35(12):2138–2146. doi:10.1093/ndt/gfz146
   PubMed Web of Science ®Google Scholar
• Kolbrink B, Schussel K, von Samson-Himmelstjerna FA, et al. Patient-focused outcomes after initiation of dialysis for ESRD: mortality, hospitalization, and functional impairment. Nephrol Dial Transplant. 2023;38(11):2528–2536. doi:10.1093/ndt/gfad099
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–180. doi:10.1016/S0140-6736(11)60178-5
   PubMed Web of Science ®Google Scholar
• Tonelli M, Wiebe N, Guthrie B, et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015;88(4):859–866. doi:10.1038/ki.2015.228
   PubMed Web of Science ®Google Scholar
• Ishigami J, Grams ME, Chang AR, et al. CKD and risk for hospitalization with infection: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2017;69(6):752–761. doi:10.1053/j.ajkd.2016.09.018
   PubMed Web of Science ®Google Scholar
• Wong E, Ballew SH, Daya N, et al. Hospitalization risk among older adults with chronic kidney disease. Am J Nephrol. 2019;50(3):212–220. doi:10.1159/000501539
   PubMed Web of Science ®Google Scholar
• Su G, Iwagami M, Qin X, et al. Kidney disease and mortality in patients with respiratory tract infections: a systematic review and meta-analysis. Clin Kidney J. 2021;14(2):602–611. doi:10.1093/ckj/sfz188
   PubMed Web of Science ®Google Scholar
• Bowe B, Xie Y, Li T, et al. Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the Global Burden of Disease study. JAMA Network Open. 2018;1(7):e184412. doi:10.1001/jamanetworkopen.2018.4412
   PubMed Web of Science ®Google Scholar
• Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–1304. doi:10.1001/jama.2019.14745
   PubMed Web of Science ®Google Scholar
• Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8(1):117. doi:10.1186/1471-2458-8-117
   PubMed Web of Science ®Google Scholar
• Bowling CB, Sharma P, Fox CS, O’Hare AM, Muntner P. Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010. JAMA. 2013;310(12):1284–1286. doi:10.1001/jama.2013.252441
   PubMed Web of Science ®Google Scholar
• Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013;62(2):245–252. doi:10.1053/j.ajkd.2013.03.009
   PubMed Web of Science ®Google Scholar
• Vlasschaert ME, Bejaimal SA, Hackam DG, et al. Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis. 2011;57(1):29–43. doi:10.1053/j.ajkd.2010.08.031
   PubMed Web of Science ®Google Scholar
• Grams ME, Plantinga LC, Hedgeman E, et al. Validation of CKD and related conditions in existing data sets: a systematic review. Am J Kidney Dis. 2011;57(1):44–54. doi:10.1053/j.ajkd.2010.05.013
   PubMed Web of Science ®Google Scholar
• Fleet JL, Dixon SN, Shariff SZ, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14(1):81. doi:10.1186/1471-2369-14-81
   PubMedGoogle Scholar
• Ronksley PE, Tonelli M, Quan H, et al. Validating a case definition for chronic kidney disease using administrative data. Nephrol Dial Transplant. 2012;27(5):1826–1831. doi:10.1093/ndt/gfr598
   PubMed Web of Science ®Google Scholar
• van Oosten MJM, Brohet RM, Logtenberg SJJ, et al. The validity of Dutch health claims data for identifying patients with chronic kidney disease: a hospital-based study in the Netherlands. Clin Kidney J. 2021;14(6):1586–1593. doi:10.1093/ckj/sfaa167
   PubMed Web of Science ®Google Scholar
• Weckmann G, Wirkner J, Kasbohm E, et al. Monitoring and management of chronic kidney disease in ambulatory care - analysis of clinical and claims data from a population-based study. BMC Health Serv Res. 2022;22(1):1330. doi:10.1186/s12913-022-08691-y
   PubMed Web of Science ®Google Scholar
• Muntner P, Gutierrez OM, Zhao H, et al. Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2015;65(2):249–258. doi:10.1053/j.ajkd.2014.07.012
   PubMed Web of Science ®Google Scholar
• Paik JM, Patorno E, Zhuo M, et al. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data. Pharmacoepidemiol Drug Saf. 2022;31(4):467–475. doi:10.1002/pds.5398
   PubMed Web of Science ®Google Scholar
• Roy L, Zappitelli M, White-Guay B, et al. Agreement between administrative database and medical chart review for the prediction of chronic kidney disease G category. Can J Kidney Health Dis. 2020;7:1–13. doi:10.1177/2054358120959908
   Google Scholar
• Eknoyan G, Lameire N, Eckardt K, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):5–14. doi:10.1038/kisup.2012.77
   Web of Science ®Google Scholar
• Schaeffner ES, van der Giet M, Gaedeke J, et al. The Berlin Initiative Study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol. 2010;25(3):203–210. doi:10.1007/s10654-010-9424-x
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. doi:10.1136/bmj.h5527
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Cochran WG. Some methods for strengthening the common χ2 tests. Biometrics. 1954;10(4):417–451. doi:10.2307/3001616
   Web of Science ®Google Scholar
• Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11(3):375–386. doi:10.2307/3001775
   Web of Science ®Google Scholar
• Douros A, Schneider A, Ebert N, et al. Control of blood pressure in older patients with heart failure and the risk of mortality: a population-based prospective cohort study. Age Ageing. 2021;50(4):1173–1181. doi:10.1093/ageing/afaa261
   PubMed Web of Science ®Google Scholar
• Douros A, Tolle M, Ebert N, et al. Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study. Eur Heart J. 2019;40(25):2021–2028. doi:10.1093/eurheartj/ehz071
   PubMed Web of Science ®Google Scholar
• Stolpe S, Scholz C, Stang A, et al. Eine chronische Niereninsuffizienz, auch in höherem Stadium, ist Patienten häufig unbekannt - aber warum wissen Frauen noch seltener von ihrer Erkrankung als Männer? [High patient unawareness for chronic kidney disease even in later stages - but why is it more frequent in women than in men?] Dtsch Med Wochenschr. 2022;147(17):e70–e81. German. doi:10.1055/a-1819-0870
   PubMedGoogle Scholar
• Hodlmoser S, Winkelmayer WC, Zee J, et al. Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018. PLoS One. 2020;15(12):e0243431. doi:10.1371/journal.pone.0243431
   PubMed Web of Science ®Google Scholar
• Kim DH, Schneeweiss S, Glynn RJ, et al. Measuring frailty in Medicare data: development and validation of a claims-based frailty index. J Gerontol a Biol Sci Med Sci. 2018;73(7):980–987. doi:10.1093/gerona/glx229
   PubMed Web of Science ®Google Scholar
• Desai RJ, Lin KJ, Patorno E, et al. Development and preliminary validation of a Medicare claims-based model to predict left ventricular ejection fraction class in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2018;11(12):e004700. doi:10.1161/CIRCOUTCOMES.118.004700
   PubMed Web of Science ®Google Scholar
• Mansour O, Paik JM, Wyss R, et al. A novel chronic kidney disease phenotyping algorithm using combined electronic health record and claims data. Clin Epidemiol. 2023;15:299–307. doi:10.2147/CLEP.S397020
   PubMed Web of Science ®Google Scholar
• Warnock DG, Muntner P, McCullough PA, et al. Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis. 2010;56(5):861–871. doi:10.1053/j.ajkd.2010.05.017
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93–104. doi:10.1038/ki.2010.531
   PubMed Web of Science ®Google Scholar
• Kühn A, van der Giet M, Kuhlmann MK, et al. Kidney function as risk factor and predictor of cardiovascular outcomes and mortality among older adults. Am J Kidney Dis. 2021;77(3):386–396. doi:10.1053/j.ajkd.2020.09.015
   PubMed Web of Science ®Google Scholar
• Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081. doi:10.1016/S0140-6736(10)60674-5
   PubMed Web of Science ®Google Scholar
• Lee M, Saver JL, Chang KH, et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010;341:c4249. doi:10.1136/bmj.c4249
   PubMed Web of Science ®Google Scholar
• D’Angelo K, Paul S, Ranjeeta F, et al. Awareness and knowledge among internal medicine house-staff for dose adjustment of cardiovascular drugs in chronic kidney disease. High Blood Press Cardiovasc Prev. 2021;28(2):177–184. doi:10.1007/s40292-021-00438-w
   PubMed Web of Science ®Google Scholar
• Karsch-Volk M, Schmid E, Wagenpfeil S, et al. Kidney function and clinical recommendations of drug dose adjustment in geriatric patients. BMC Geriatr. 2013;13(1):92. doi:10.1186/1471-2318-13-92
   PubMedGoogle Scholar
• Matzke GR, Aronoff GR, Atkinson AJ, et al. Drug dosing consideration in patients with acute and chronic kidney disease-A clinical update from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2011;80(11):1122–1137. doi:10.1038/ki.2011.322
   PubMed Web of Science ®Google Scholar
• Schaeffner ES, Ebert N, Kuhlmann MK, et al. Age and the course of GFR in persons aged 70 and above. Clin J Am Soc Nephrol. 2022;17(8):1119–1128. doi:10.2215/CJN.16631221
   PubMed Web of Science ®Google Scholar